Genworth Financial (GNW) Q2 2025 earnings summary

Executive summary

• Net income for Q2 2025 was $51 million ($0.12 per diluted share), down from $76 million in Q2 2024; adjusted operating income was $68 million ($0.16 per share), with Enact contributing $141 million and $94 million in capital returns.

• Enact remains a key cash flow source, with over $1 billion in capital returns since its IPO and $400 million expected to be returned to shareholders in 2025.

• Strategic priorities include leveraging Enact, maintaining self-sustaining legacy LTC/life/annuity businesses, and driving growth through CareScout's expanded offerings and network.

• Shareholder value creation continued through $30 million in Q2 share repurchases, totaling $620 million since inception and reducing shares outstanding by 19%.

• Favorable UK High Court ruling in the AXA Payment Protection Insurance case could result in up to $750 million recovery, pending appeals.

Financial highlights

• Total revenues for Q2 2025 were $1.80 billion, up 2% year-over-year; net investment income was $802 million, with $28 million in net investment losses.

• Adjusted operating income for Q2 was $68 million, primarily driven by Enact, while LTC insurance posted a $37 million loss and life/annuities a $7 million loss.

• Enact's primary insurance in force grew 1% year-over-year to $270 billion, with primary new insurance written up 35% sequentially.

• Statutory pre-tax income for U.S. Life Insurance companies was $81 million for the quarter.

• Weighted-average diluted shares declined to 417.5 million from 440.7 million year-over-year due to share repurchases.

Outlook and guidance

• Enact expects to return approximately $400 million to shareholders in 2025, with Genworth's share estimated at $325 million.

• CareScout targets 2,850 matches for 2025, with 55% of the annual target achieved by Q2 and expansion to new customers and jurisdictions underway.

• 2025 investment in CareScout Insurance increased to $85 million to meet regulatory capital requirements.

• Share repurchases for 2025 expected to be $100 million–$150 million, excluding potential AXA litigation proceeds.

• Management expects continued volatility in LTC insurance results due to assumption updates and actual experience variances.